Silicon Laboratories
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Silicon Laboratories's revenues will grow 5.8% and EPS will wane -2.0%.
The average estimate for revenue is $143.6 million. On the bottom line, the average EPS estimate is $0.50.
Revenue details
Last quarter, Silicon Laboratories notched revenue of $145.4 million. GAAP reported sales were 16% higher than the prior-year quarter's $125.7 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
Last quarter, non-GAAP EPS came in at $0.59. GAAP EPS of $0.46 for Q1 were 39% higher than the prior-year quarter's $0.33 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
Recent performance
For the preceding quarter, gross margin was 60.1%, 40 basis points better than the prior-year quarter. Operating margin was 12.6%, much about the same as the prior-year quarter. Net margin was 13.8%, 240 basis points better than the prior-year quarter.
Looking ahead
The full year's average estimate for revenue is $596.8 million. The average EPS estimate is $2.27.
Investor sentiment
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 350 members out of 378 rating the stock outperform, and 28 members rating it underperform. Among 129 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 127 give Silicon Laboratories a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Silicon Laboratories is outperform, with an average price target of $50.12.
Is Silicon Laboratories the best semiconductor stock for you? You may be missing something obvious. Check out the semiconductor company that Motley Fool analysts expect to lead "The Next Trillion-dollar Revolution." Click here for instant access to this free report.
- Add Silicon Laboratories to My Watchlist.